Coagulopathy in pregnant women with COVID-19
DOI:
https://doi.org/10.33448/rsd-v10i16.22040Keywords:
Pregnant; Pregnant woman; Coagulopathy; Blood disease; COVID-19.Abstract
The current COVID-19 pandemic caused by the new SARSCoV-2 coronavirus, spread rapidly and resulted in numerous fatal cases. Coagulopathy is one of the main complications of this disease, and it can occur in any patient infected by the virus; one of the risk groups, obstetric patients, requires more attention, due to coagulative and hemostatic changes expected in this group. The purpose of the review was to conduct a literature review of articles that address the relationship between hypercoagulopathy and pregnant women infected by the SARS-COV-2 virus. The search was performed in Google Scholar, Virtual Health Library (BVS), Scientific Electronic Library Online (Scielo) and PubMed databases. The following descriptors were used “pregnant women”, “coagulopathy”, “blood disease”, “COVID-19”, “haematological alterations”. Bleeding disorders occur in patients who are pregnant or not infected by the SARS-COV-2. Pregnant women are a group more susceptible to aggravations, due to the hypercoagulability process that already occurs naturally in the gestational period. More studies are needed to show this association, in order to provide adequate care for such patients.
References
Assunção, P., Costa, E & Dantas, E. (2017). Perfil epidemiológico das coagulopatias hereditárias no estado de alagoas no período de 2011 – 2015. Centro Universitário Tiradentes – UNIT.
Barca, D. et al. (2010). Hemovida web coagulopatias: um relato de seu processo de desenvolvimento e implementação. Hemovida web coagulopatias, 434-444.
Benhamou, D., Keita, H. & Ducloy-bouthors, A. S. (2020). Obstetric Anaesthesia and Critical Care Club Working Group (2020). Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesthesia, critical care & pain medicine, 39 (3), 351–353. doi: 10.1016/j.accpm.2020.05.003.
Cubas, J. et al. (2020). Maternal mortality in pregnant woman with positive sars-cov-2 antibodies and severe preeclampsia. report of cases. Rev Peru Obstet. 2020; 66, 1-6.
Dashraath, P. et al. (2020). Coronavírus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol.
Geng, YJ et al. (2020). Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovascular Pathology. 47..
Giannis, D., Ziogas, I. & Gianni, P. (2020) Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology.
Gorziza, R. (2020). Avaliação laboratorial de coagulopatias e trombpfilias hereditárias. https://www.lume.ufrgs.br/bitstream/handle/10183/186447/Resumo_12373.pdf?sequence=l.
Gunduz, Z. (2021). Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report. São Paulo Med J. doi: https://doi.org/10.1590/1516-3180.2020.0659.R1.08122020.
Iba, T. et al. (2020). Coagulopathy in COVID-19. J Thromb Haemost; 18, 2103– 2109. doi: https://doi.org/10.1111/jth.14975,
Iba, T. et al. (2020). Coagulopathy of Coronavirus Disease 2019. Critical care medicine, 48, (9), 1358-1364. doi: https://doi.org/10.1097/CCM.0000000000004458.
Javanmard, S., Heshmat-ghahdarijani, K. & Vaseghi, G. (2020). Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. Infection Control & Hospital Epidemiology, 1-2.
Kadir, R. et al. (2020). Covid-19 coagulopathy in pregnancy: critical review, preliminary recommendations, and isth registry—communication from the isth ssc for women’s health. International Society on Thrombosis and Haemostasis. doi: doi: 10.1111/JTH.15072.
Kang, Y. et al. (2020). Cardiovascular manifestations and treatment considerations in COVID-19. Heart, 106(15), 1132-114.
Koumoutsea, E. et al. (2020). COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost, 18, 1648– 1652. doi: https://doi.org/10.1111/jth.14856.
Lin, L. et al. (2020). Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Emerging Microbes & Infections. 9(1), 727-732.
Makatsariya, A. et al. (2020). Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state. The journal of maternal-fetal & neonatal medicine. doi: https://doi.org/10.1080/14767058.2020.1786811.
Ministério da Saúde (BR). (2002). Relatório estatístico do cadastro de coagulopatias hereditárias. Agência Nacional de Vigilância Sanitária (ANVISA). http://bvsms.saude.gov.br/bvs/publicacoes/perfil_coagulopatias_ hereditarias_2002.pdf.
Mongula, J. et al. (2020). Covid-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Department of Obstetrics and Gynecology, Máxima Medical Centre. doi: https://doi.org/10.1002/uog.22189.
Moreira, A. et al. (2009). Fatores de risco associados a trombose em pacientes do estado do ceará. Revista brasileira de hematologia e hemoterapia, 132-136.
Nascimento, B., Scarpelini, S. & Rizoli, S. (2007). Coagulopatia no trauma. Medicina (Ribeirão Preto), 40 (4), 509-517. doi: 10.11606/issn.2176-7262.v40i4p509-517.
Nesr, G. et al. (2020). Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: A case report. British Society for Haematology and John Wiley & Sons Ltd. doi: https://doi.org/10.1111/bjh.16928.
Panigada, M. et al. (2020). Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. https://pubmed.ncbi.nlm.nih.gov/32302438/.
Prabhu, M. et al. (2020). Pregnancy and postpartum outcomes in a universally tested population for sars-cov-2 in new york city: a prospective cohort study. An international Journal of obstetrics and gynecology – Royal College of obstetricians and gynecologists, p 1548 – 1556.
Ranucci, M. et al. (2020). The procoagulant pattern of patients with Covid-19 acute respiratory distress syndrome. J Thromb Haemost. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/32302448/.
Rodrigues, C., Baia, I., Domingues, R. & Barros, H. (2020). Pregnancy and breastfeeding during covid-19 pandemic: a systematic review of published pregnancy cases. Frontiers in public health, 8, 1-13.
Ronnie, L. et al. (2020). Complicated COVID-19 in pregnancy: a case report with severe liver and coagulation dysfunction promptly improved by delivery. BMC Pregnancy Childbirth, 20, 511. doi: https://doi.org/10.1186/s12884-020-03172-8.
Rostami, M. & Mansouritorghabeh, H. (2020). D-dimer level in COVID-19 infection: a systematic review. Expert review of hematology, 13 (11), 1265–1275. doi: https://doi.org/10.1080/17474086.2020.1831383 .
Saposnik, G. et al. (2011). Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals. American Heart Association/American Stroke Association, 42 (4), 1158-92. doi: http://doi.org/10.1161/STR.0b013e31820a8364.
Servante, J. et al. (2021). Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth, 21, 108. doi: https://doi.org/10.1186/s12884-021-03568-0.
Su, S. et al. (2016). Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends in Microbiology, 24 (6), 490-502.
Tang, N. et al. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18, 844–847. doi: https://pubmed.ncbi.nlm.nih.gov/32073213/.
Vivas, D. et al. (2020). Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología. Revista Española de Cardiología, 73(9), 749-757.
Wiersinga, W. et al. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). JAMA, 324(8), 782.
Wisniewski, D. & Kluthcovsky, A. (2008). O Perfil dos Pacientes Portadores de Coagulopatias de uma Região do Sul do Brasil. Cogitare Enferm. doi: http://dx.doi.org/10.5380/ce.v13i2.12485.
Xu, Y. et al. (2020). Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. Journal of Infection, 80(4), 394-400.
Yao, X. et al. (2020). Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Research, 30(6), 541-543.
Zhu, N. et al. (2020). A novel Coronavirus from patients with pneumonia in China, 2019. N Eng J Med, 1-7. doi: 10.1056/NEJMoa2001017.
Zoller, M., Irlbeck, M. & Zwissler, B. (2020). Coronavirus Disease. Der Anaesthesist, 222-223.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Júlia de Lima Santos; Thatiany Santos Araújo; João Junior Scapin Telis; Mikael Santana dos Santos; Jennifer Soares de Almeida; Thalita Grazielly Santos; Nicole Blanco Bernardes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
